Navigation Links
Solutia Opens New Photovoltaic Laboratory

SPRINGFIELD, Mass., Oct. 12 /PRNewswire/ -- Solutia Inc. (NYSE: SOA), a market-leading performance materials and specialty chemicals company, has opened a new Photovoltaic Laboratory Center to develop innovative solutions that support the fast-growing solar energy market.



The state-of-the-art facility is a testament to Solutia's commitment to the fast-growing solar energy market and follows a series of recent solar energy investments, including the purchase of Etimex Solar GmbH and planned expansions of its polyvinyl butyral (PVB) interlayer and ethylene vinyl acetate (EVA) encapsulant production in China—branded as Saflex® PVB encapsulant and Vistasolar® EVA encapsulant. The new facility is located in the Indian Orchard part of Springfield, Massachusetts, USA.

"Demand for renewable energy is growing, and that drives the demand for innovative technologies and materials," comments Aristotelis Karagiannis, vice president of technology, Solutia's Advanced Interlayers division. "With our deep understanding of EVA and PVB technologies, a track record of rapid innovation and our new laboratory, we're in a unique position to develop and deliver high-value solutions for the solar module market."

The new facility is designed to spur breakthrough innovations, accelerate new product development timelines and provide expert technical service to the makers of solar modules. The center is operated by a photovoltaic development team of EVA and PVB experts in chemistry, physics, polymer design and formulation and polymer processing.

“We knew that the acquisition of Etimex Solar GmbH was going to provide synergistic opportunities for EVA and PVB product development and support,” said Eric Nichols, vice president, Solutia’s Advanced Interlayers division.  "Our new laboratory houses our experts and provides them with state-of-the-art equipment to drive these technologies plus further enhances our ability to solve customer problems including process improvements."

To help accelerate the commercialization of new products, module manufacturers can utilize Solutia's improved ability to perform key International Electrotechnical Commission (IEC) tests for new module packages prior to formal testing submissions. The laboratory also provides full capabilities for all photovoltaic encapsulation processes and pilot production of encapsulants.

"The new laboratory is a one-stop shop for the development of photovoltaic solutions" Karagiannis said. "It helps put Solutia and our customers on the leading edge of the high-growth renewable energy market."

NOTE TO EDITORS: Solutia, Saflex and Vistasolar are trademarks of Solutia Inc. and/or its subsidiaries. Etimex Solar is a trademark of Etimex Holding GmbH.  

Corporate Profile

Solutia is a market-leading performance materials and specialty chemicals company. The company focuses on providing solutions for a better life through a range of products, including: Saflex® polyvinyl butyral interlayers for glass lamination and for photovoltaic module encapsulation and Vistasolar® ethylene vinyl acetate films for photovoltaic module encapsulation;  LLumar®, Vista™, FormulaOne®, Gila®, EnerLogic™, V-KOOL®, Huper Optik®, IQue™, Sun-X® and Nanolux® aftermarket performance films for automotive and architectural applications; Flexvue™ advanced film component solutions for solar and electronic technologies; and technical specialties products including Crystex® insoluble sulfur, Santoflex® PPD antidegradants, Therminol® heat transfer fluids and Skydrol® aviation hydraulic fluids. Solutia's businesses are world leaders in each of their market segments. With its headquarters in St. Louis, Missouri, USA, the company operates globally with approximately 3,400 employees in more than 50 worldwide locations. More information is available at

SOURCE Solutia Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Solutia to Present at Credit Suisse Future Energy Conference
2. Solutia Reports Third Quarter 2009 Results
3. Solutia Reports First Quarter 2009 Results
4. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
5. MPM Capital Opens Midwest Office
6. Single electron reader opens path for quantum computing
7. Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance
8. Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania
9. PRA International Opens Phase I Unit in Budapest
10. Beike Biotechnology Opens Worlds Largest Stem Cell Storage and Processing Facility
11. Brooks Instrument Opens Pressure Gauge Production Line
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... Pittcon is pleased to announce the 2016 ... symposia, oral sessions, workshops, awards, and posters. The core of the Technical ... as, but not limited to, biotechnology, biomedical, drug discovery, environmental, food science, fuels/energy, ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
Breaking Biology News(10 mins):